Seacole gets new captain to manage growth

Personalised clinical study services firm mdgroup has appointed Steph Katz as director of its business subsidiary Seacole Health.

Seacole Health combines mdgroup’s mobile health and clinical research staff resourcing.

Katz started out as an oncology nurse in intensive care units, before taking a management role, helping to develop and operationalise institutional, federal and commercial clinical research projects, and pursuing an MBA.

Tarquin Scadding-Hunt, CEO of mdgroup, said: “Steph’s experience working on the site and sponsor side of clinical research, combined with 16 years as a registered nurse, eight years as a clinical research trainer and her business sense, gives her the ability to move Seacole Health forward as a business that uniquely meets the changing needs of the post-COVID healthcare workforce.”

Katz said: “I am excited to bring my love of nursing and clinical research together in service of our mission to provide remarkable patient experiences in the decentralised trial space.

“I am passionate about ensuring we honour our participants by collecting the highest-quality data. They give of themselves for the betterment of humankind and we owe it to them to make sure we translate their experience as accurately as possible.”

Steph has a Bachelor of Science in Nursing from the University of Delaware, a Masters of Science in Nursing Education from Drexel University’s College of Nursing and Health Professions and is currently completing an MBA at The John Hopkins University.

Her previous roles include research nurse manager at The John Hopkins University School of Medicine and Clinical Trial Manager at Evon Medics.